Pharma's new marketing mix brings closer collaboration with sales reps

While pharma experienced a massive shift to digital sales brought on by the COVID-19 pandemic moving forward, a marketing mix that includes in-person touch points remains integral to building strong relationships in the pharmaceutical marketing industry.

That’s according to Dan Rizzo, Veeva Systems' head of global business consulting, who explained in an interview that pharma needs to be shifting sales and marketing tactics in this new, so-called “blended environment,” which includes developing a new sales compensation model for the future.